These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24084852)

  • 1. [The relevance of biomarkers for personalised medicine].
    Großhennig A; Benda N; Koch A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1480-8. PubMed ID: 24084852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Personalised medicine. Aims and challenges].
    Bieber T; Broich K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1468-72. PubMed ID: 24170075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Special considerations for the regulation of biological medicinal products in individualised medicine. More than stratified medicine].
    Müller-Berghaus J; Volkers P; Scherer J; Cichutek K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1538-44. PubMed ID: 24170083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of companion diagnostic device measurement performance on clinical validation of personalized medicine.
    Li M; Yu T; Hu YF
    Stat Med; 2015 Jun; 34(14):2222-34. PubMed ID: 25779099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Personalised medicine in psychiatry and psychotherapy. A review of the current state-of-the-art in the biomarker-based early recognition of psychoses].
    Koutsouleris N; Ruhrmann S; Falkai P; Maier W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1522-30. PubMed ID: 24170081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biostatistic tools in pharmacogenomics--advances, challenges, potential.
    Sato Y; Laird NM; Yoshida T
    Curr Pharm Des; 2010; 16(20):2232-40. PubMed ID: 20459388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized medicine: Time for one-person trials.
    Schork NJ
    Nature; 2015 Apr; 520(7549):609-11. PubMed ID: 25925459
    [No Abstract]   [Full Text] [Related]  

  • 8. [Personalised medicine for the diagnosis and treatment of allergic diseases].
    Vieths S; Bieber T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1531-7. PubMed ID: 24170082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized medicine in children with asthma.
    Pijnenburg MW; Szefler S
    Paediatr Respir Rev; 2015 Mar; 16(2):101-7. PubMed ID: 25458797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Personalised medicine].
    Broich K; Bieber T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1465-7. PubMed ID: 24170074
    [No Abstract]   [Full Text] [Related]  

  • 11. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biomarker analysis from a pathologist's view. Founding the rationale for personalised treatment of lung cancer].
    Buettner R; Heydt C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1502-8. PubMed ID: 24170079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining drug response for stratified medicine.
    Lonergan M; Senn SJ; McNamee C; Daly AK; Sutton R; Hattersley A; Pearson E; Pirmohamed M
    Drug Discov Today; 2017 Jan; 22(1):173-179. PubMed ID: 27818254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.
    Blaus A; Madabushi R; Pacanowski M; Rose M; Schuck RN; Stockbridge N; Temple R; Unger EF
    Circulation; 2015 Oct; 132(15):1425-32. PubMed ID: 26459078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individually tailored immunosuppression: is there a role for biomarkers?
    Brandhorst G; Oellerich M; Brunet M; Kowalski R; Vinks A; Wallemacq P
    Clin Chem; 2011 Mar; 57(3):376-81. PubMed ID: 21228253
    [No Abstract]   [Full Text] [Related]  

  • 16. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
    Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
    Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care.
    Schneider D; Bianchini G; Horgan D; Michiels S; Witjes W; Hills R; Plun-Favreau J; Brand A; Lawler M;
    Public Health Genomics; 2015; 18(6):349-58. PubMed ID: 26571110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does personalized medicine exist and can you test it in a clinical trial?
    Sandercock PA
    Int J Stroke; 2015 Oct; 10(7):994-9. PubMed ID: 26282857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of bioinformatics in personalised medicine].
    Lengauer T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1489-94. PubMed ID: 24170077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic phenotype prediction from genotyping data: a bottleneck for the implementation of pharmacogenetics in drug development and clinical practice.
    LLerena A; Peñas-Lledó EM
    Drug Metab Pers Ther; 2015 Sep; 30(3):143-5. PubMed ID: 26353178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.